Advisory Research Inc Ultragenyx Pharmaceutical Inc. Transaction History

Advisory Research Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$106.9 - $167.73 $470,680 - $738,515	-4,403 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $695,793 - $1.46 Million	-8,244 Reduced 65.19%	4,403 $610,000
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $282,286 - $348,120	3,868 Added 44.06%	12,647 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $411,822 - $686,693	8,779 New	8,779 $687,000
Q4 2018 Feb 13, 2019	SELL	$38.89 - $77.3 $873,819 - $1.74 Million	-22,469 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.81 - $90.15 $1.61 Million - $2.03 Million	22,469 New	22,469 $1.72 Million

325

85.6M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.88B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.